Skip to main content
. 2022 Apr 23;27(9):2725. doi: 10.3390/molecules27092725

Figure 5.

Figure 5

Nano-PSO treatment significantly reduced the elevation of activated astrocytes in the cortex of TBI mice: (A) Coronal sections through the temporal cortex of brains from treated and untreated controls, as well as from untreated TBI, treated with Nano-PSO before TBI and treated with Nano-PSO Post-TBI were immunostained for GFAP (red) and DAPI (blue) [scale bar 50 µm]; (B) Quantitative assessment of GFAP immunostaining for all sections (bregma temporal cortex -1.06nm) at the end point of each experiment was quantified using One-way ANOVA ((PRE: F (3, 8) = 7.741, p = 0.000 Fisher’s LSD post hoc, *** p < 0.001, n = 3) (POST: F (3, 16) = 6.679, p = 0.001 Fisher’s LSD post hoc, ** p < 0.01, n = 5)). NS = Not significant. Values are presented as mean ± SEM.